Application

18400974 · IGM FC AND J-CHAIN MUTATIONS THAT AFFECT IGM SERUM HALF-LIFE

Filed 2023-12-29 · Granted · Patent 12649791 (2026-06-09) The official file ↗The patent and its PDF ↗ · Art unit 1641 · Examiner Phuong N Huynh Typical · CPC C07K 16/2809 · IGM Biosciences, Inc. · STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

12.0 mo

to disposition 29.3 mo

Statutes raised

112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.